Page last updated: 2024-10-26

dipivefrin and Corneal Neovascularization

dipivefrin has been researched along with Corneal Neovascularization in 1 studies

dipivefrin: used in treatment of both primary & open angle glaucoma; RN given refers to (+-)-isomer
dipivefrin : The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.

Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.

Research Excerpts

ExcerptRelevanceReference
"Dipivefrin hydrochloride is a lipophilic prodrug for epinephrine hydrochloride, allowing lower concentration of the drug to achieve the same intraocular pressure lowering effect and having also less harmful effects than epinephrine hydrochloride."1.29Corneal vascularization and opacification during long-term use of dipivefrin. ( Hakala, T; Helin, H; Krootila, K; Salminen, L, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salminen, L1
Krootila, K1
Helin, H1
Hakala, T1

Other Studies

1 other study available for dipivefrin and Corneal Neovascularization

ArticleYear
Corneal vascularization and opacification during long-term use of dipivefrin.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1995,Spring, Volume: 11, Issue:1

    Topics: Blepharitis; Conjunctival Diseases; Corneal Neovascularization; Corneal Opacity; Epinephrine; Female

1995